ArticleBioengineering (Basel, Switzerland)2025
Improving Benign and Malignant Classifications in Mammography with ROI-Stratified Deep Learning.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Improving Normal/Abnormal and Benign/Malignant Classifications in Mammography with ROI-Stratified Deep Learning.Bioengineering (Basel, Switzerland) · 2026Article
- Calibrated Transformer Fusion for Dual-View Low-Energy CESM Classification.Journal of imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deep learning has achieved widespread adoption for medical image diagnosis, with extensive research dedicated to mammographic image analysis for breast cancer screening. This study investigates the hypothesis that incorporating region-of-interest (ROI) mask information for individual mammographic images during deep learning can improve the accuracy of benign/malignant diagnoses. Swin Transformer and ConvNeXtV2 deep learning models were used to evaluate their performance on the public VinDr and CDD-CESM datasets. Our approach involved stratifying mammographic images based on the presence or absence of ROI masks, performing independent training and prediction for each subgroup, and subsequently merging the results. Baseline prediction metrics (sensitivity, specificity, F-score, and accuracy) without ROI-stratified separation were the following: VinDr/Swin Transformer (0.00, 1.00, 0.00, 0.85), VinDr/ConvNeXtV2 (0.00, 1.00, 0.00, 0.85), CDD-CESM/Swin Transformer (0.29, 0.68, 0.41, 0.48), and CDD-CESM/ConvNeXtV2 (0.65, 0.65, 0.65, 0.65). Subsequent analysis with ROI-stratified separation demonstrated marked improvements in these metrics: VinDr/Swin Transformer (0.93, 0.87, 0.90, 0.87), VinDr/ConvNeXtV2 (0.90, 0.86, 0.88, 0.87), CDD-CESM/Swin Transformer (0.65, 0.65, 0.65, 0.65), and CDD-CESM/ConvNeXtV2 (0.74, 0.61, 0.67, 0.68). These findings provide compelling evidence that validate our hypothesis and affirm the utility of considering ROI mask information for enhanced diagnostic accuracy in mammography.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.